EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic Molecular Alterations of TP53, SIRT-1, and miR-34a Expression in Atrial Fibrillation: A Prospective Exploratory Biomarker Study

Monika Różycka-Kosmalska, Izabela Szymczak-Pajor iD, Agnieszka Śliwińska iD, Małgorzata Kozłowska, Jerzy Krzysztof Wranicz iD, Marcin Kosmalski iD

International Journal of Molecular Sciences · 22.06.2026 · 27 (12) · 5633

DOI: 10.3390/ijms27125633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.06.2026. Verfasst von Monika Różycka-Kosmalska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrocardiology, Medical University of Lodz, 92-213 Lodz, Poland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Sirtuin 1, MicroRNAs, Tumor Suppressor Protein p53. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

p53, miR-34a, and SIRT-1 are involved in cellular stress responses, senescence, and inflammation—processes central to the pathophysiology of atrial fibrillation (AF). In this study, circulating TP53 and SIRT-1 serum miR-34a expression were determined in patients with and without AF, in order to assess their associations with AF. We also checked their potential diagnostic utility as systemic biomarkers associated with AF. The study included 189 adults, 94 AF+, 95 AF−. Clinical, anthropometric, and biochemical data were collected. Whole-blood TP53 and SIRT-1 mRNA expression and serum miR-34a expression were quantified by RT-qPCR. ROC analysis and Youden-derived odds ratios assessed exploratory diagnostic performance. AF patients had significantly higher expression of TP53 (0.0352 vs. 0.0253; p < 0.001) and miR-34a (0.0215 vs. 0.0099; p < 0.001), but significantly lower expression of SIRT-1 (0.0079 vs. 0.0145; p < 0.001). The level of SIRT-1 expression showed the highest discriminatory performance (exploratory AUC = 0.6987; p < 0.0001). TP53 expression levels exceeding 0.0295 were associated with nearly threefold higher odds of AF (OR = 2.92, 95% CI: 1.61–5.28, p = 0.0006), whereas the expression levels of SIRT-1 and miR-34a were not significantly associated with AF in cut-off analysis. In the AF group, a positive correlation was found between the expression of TP53 and SIRT-1 (Rho = 0.3609, p < 0.001); however, it was not consistent with a canonical model of miR-34a-mediated SIRT-1 suppression. In turn, the expression of miR-34a correlated positively with age and C-reactive protein level and negatively with estimated glomerular filtration rate (eGFR). The obtained results suggest that AF is associated with altered expression of circulating TP53, SIRT-1, and miR-34a. However, due to the fact that the expression levels were measured in peripheral compartments, and not in atrial tissue, the obtained results should not be interpreted as direct evidence of AF-related atrial remodeling. For these reasons, further investigations involving simultaneous measurements of the TP53/miR-34a/SIRT-1 regulatory axis, both in the circulating compartment and atrial tissue, should be performed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationSirtuin 1MicroRNAsTumor Suppressor Protein p53HumansFemaleBiomarkersMaleAgedMiddle AgedProspective StudiesGene Expression RegulationROC Curve

Stichwörter der Autor:innen

SIRT-1TP53atrial fibrillationatrial remodelingmiR-34a

Substanzen

Sirtuin 1MicroRNAsTumor Suppressor Protein p53MIRN34 microRNA, humanBiomarkersSIRT1 protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Department of Electrocardiology, Medical University of Lodz, 92-213 Lodz, Poland.
  • Department of Nucleic Acid Biochemistry, Medical University of Lodz, 92-213 Lodz, Poland.
  • Department of Clinical Pharmacology, Medical University of Lodz, 90-153 Lodz, Poland.

ORCID-Profile: Izabela Szymczak-Pajor, Agnieszka Śliwińska, Jerzy Krzysztof Wranicz, Marcin Kosmalski

Förderung

  • Medical University of Lodz

Zitieren

APA

Różycka-Kosmalska, M., Szymczak-Pajor, I., Śliwińska, A., Kozłowska, M., Wranicz, J. K., & Kosmalski, M. (2026). Systemic Molecular Alterations of TP53, SIRT-1, and miR-34a Expression in Atrial Fibrillation: A Prospective Exploratory Biomarker Study. International Journal of Molecular Sciences, 27(12), 5633. https://doi.org/10.3390/ijms27125633

Vancouver

Różycka-Kosmalska M, Szymczak-Pajor I, Śliwińska A, Kozłowska M, Wranicz JK, Kosmalski M. Systemic Molecular Alterations of TP53, SIRT-1, and miR-34a Expression in Atrial Fibrillation: A Prospective Exploratory Biomarker Study. International Journal of Molecular Sciences. 2026;27(12):5633. doi:10.3390/ijms27125633

BibTeX
@article{RyckaKosmalska2026,
  author = {Różycka-Kosmalska, Monika and Szymczak-Pajor, Izabela and Śliwińska, Agnieszka and Kozłowska, Małgorzata and Wranicz, Jerzy Krzysztof and Kosmalski, Marcin},
  title = {Systemic Molecular Alterations of TP53, SIRT-1, and miR-34a Expression in Atrial Fibrillation: A Prospective Exploratory Biomarker Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5633},
  doi = {10.3390/ijms27125633}
}
Kostenlos starten →